Avanir Pharmaceuticals Inc. (AVNR)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Katkin Officer, Director	$2.83	62,874	$177,864.26	167,173	2010-09-01	Filing
Katkin Officer, Director	$2.86	40,000	$114,512.00	230,047	2010-08-31	Filing
Kaye Officer	$3.08	35,000	$107,663.50	248,483	2010-08-18	Filing
Ocampo Officer	$3.10	12,581	$39,001.10	41,982	2010-08-11	Filing
Ocampo Officer	$3.11	15,669	$48,730.59	54,563	2010-08-11	Filing
Kaye Officer	$3.28	10,000	$32,800.00	283,483	2010-08-05	Filing
Clarus Large Shareholder	$3.53	165,000	$583,143.00	15,392,318	2010-07-13	Filing
Kaye Officer	$3.02	10,000	$30,203.00	293,483	2010-07-07	Filing
Kaye Officer	$2.38	50,000	$119,115.00	304,930	2010-06-07	Filing
Katkin Officer, Director	$3.06	65,906	$201,375.78	271,367	2010-05-03	Filing
Katkin Officer, Director	$3.31	40,000	$132,372.00	337,273	2010-04-30	Filing
Katkin Officer, Director	$3.01	10,000	$30,100.00	377,273	2010-04-08	Filing
Katkin Officer, Director	$2.60	30,000	$78,000.00	387,273	2010-03-29	Filing
Ocampo Officer	$2.08	200	$416.16	41,982	2010-03-16	Filing
Ocampo Officer	$2.08	11,000	$22,885.50	42,182	2010-03-16	Filing
Ocampo Officer	$2.08	100	$208.02	53,182	2010-03-16	Filing
Ocampo Officer	$2.08	4,218	$8,773.44	53,282	2010-03-16	Filing
Katkin Officer, Director	$1.96	6,000	$11,766.00	418,590	2010-01-05	Filing
Katkin Officer, Director	$1.96	2,000	$3,921.00	424,590	2010-01-05	Filing
Katkin Officer, Director	$1.94	2,000	$3,880.20	426,590	2010-01-05	Filing